| | |
ALDOA-Ab
|
FH-Ab
|
|---|
|
Sex
| |
Male
|
Female
|
Male
|
Female
|
|
Sample number
| |
692
|
458
|
692
|
458
|
|
Antibody level
|
Average
|
19,087
|
18,196
|
3,323
|
3,492
|
|
SD
|
11,046
|
10,456
|
3,258
|
3,630
|
|
P value (vs Male)
| | |
0.1941
| |
0.2563
|
|
DM
| |
DM (–)
|
DM ( +)
|
DM (–)
|
DM ( +)
|
|
Sample number
| |
926
|
219
|
926
|
219
|
|
Antibody level
|
Average
|
18,637
|
19,189
|
3,315
|
3,710
|
|
SD
|
11,045
|
9,902
|
3,425
|
3,349
|
|
P value [vs DM (–)]
| | |
0.1250
| |
0.0183
|
|
Blood pressure
| |
HT (–)
|
HT ( +)
|
HT (–)
|
HT ( +)
|
|
Sample number
| |
505
|
640
|
505
|
640
|
|
Antibody level
|
Average
|
17,927
|
19,388
|
2,977
|
3,717
|
|
SD
|
11,037
|
10,635
|
2,985
|
3,685
|
|
P value [vs HT (–)]
| | |
0.0022
| |
< 0.0001
|
|
CHD
| |
CHD (–)
|
CHD ( +)
|
CHD–
|
CHD +
|
|
Sample number
| |
1086
|
59
|
1086
|
59
|
|
Antibody level
|
Average
|
18,600
|
21,373
|
3,336
|
4,397
|
|
SD
|
10,685
|
13,087
|
3,351
|
4,302
|
|
P value [vs CHD (–)]
| | |
0.0400
| |
0.0268
|
|
Lipidemia
| |
HL (–)
|
HL ( +)
|
HL (–)
|
HL ( +)
|
|
Sample number
| |
844
|
301
|
844
|
301
|
|
Antibody level
|
Average
|
18,871
|
18,384
|
3,514
|
3,045
|
|
SD
|
11,144
|
9,923
|
3,688
|
2,455
|
|
P value [vs HL (–)]
| |
0.6244
| |
0.6545
|
|
Life style
| |
Non-smoker
|
Smoker
|
Non-smoker
|
Smoker
|
|
Sample number
| |
584
|
561
|
584
|
561
|
|
Antibody level
|
Average
|
17,371
|
20,158
|
3,282
|
3,494
|
|
SD
|
9,641
|
11,783
|
3,587
|
3,186
|
|
P value (vs non-smoker)
| |
< 0.0001
| |
0.0566
|
|
Life style
| |
Alcohol (–)
|
Alcohol ( +)
|
Alcohol (–)
|
Alcohol ( +)
|
|
Sample number
| |
338
|
570
|
338
|
570
|
|
Antibody level
|
Average
|
17,928
|
19,507
|
3,528
|
3,466
|
|
SD
|
9,311
|
12,373
|
3,544
|
3,492
|
|
P value [vs Alcohol (-)]
| | |
0.0817
| |
0.8972
|
|
Obesity
| |
BMI < 25
|
BMI ≥ 25
|
BMI < 25
|
BMI ≥ 25
|
|
Sample number
| |
809
|
315
|
809
|
315
|
|
Antibody level
|
Average
|
18,911
|
18,568
|
3,577
|
2,992
|
|
SD
|
11,198
|
10,049
|
3,722
|
2,475
|
|
P value (vs BMI < 25)
| | |
0.8354
| |
0.0720
|
- The subjects were divided into two groups as follows: sex (male and female); presence ( +) or absence ( −) of complication of DM, HT, CHD or hyperlipidemia (HL), lifestyle factors (smoking and alcohol intake habits), and obesity. Antibody levels (alpha counts) were compared using the Mann–Whitney U test. Sample numbers, averages and SDs of counts as well as P values are shown. Significant correlations (P < 0.05) are marked in bold
